| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.22 | 6e-12 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-07 |